Chan-Zuckerberg’s new center in New York; Endeavor buys rights to ADC; Basilea acquires antifungal

Chan-Zucker­berg to launch new re­search ini­tia­tive in New York: Meta CEO and co-founder Mark Zucker­berg and Priscil­la Chan, his wife and a pe­di­a­tri­cian, plan to launch a fourth re­search cen­ter, this time in New York City. The cen­ter will fo­cus on new ways to study and en­gi­neer im­mune cells, with plans to in­vest $250 mil­lion over ten years, they an­nounced Wednes­day at a STAT event. New York State and New York City are al­so each con­tribut­ing $10 mil­lion. The New York pro­gram will be a col­lab­o­ra­tion be­tween Co­lum­bia Uni­ver­si­ty, Rock­e­feller Uni­ver­si­ty and Yale Uni­ver­si­ty. Co­lum­bia bi­ol­o­gist An­drea Cal­i­fano will di­rect the cen­ter. The Chan-Zucker­berg Ini­tia­tive’s oth­er bio­hubs are in San Fran­cis­co, Chica­go and Red­wood City, CA. — Lei Lei Wu

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.